Clinical Trial Update: Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 neoadjuvant approach for locally advanced rectal cancer using short-course radiotherapy followed by AK112 and CAPOX. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• AK112
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Locally Advanced Rectal Cancer, Neoadjuvant Therapy | Phase 2 | Status: RECRUITING